Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 4:36 pm Purchase | 2023-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Carlyle Group Inc. CG | 3,496,808 6.100% | 561,702 (+19.14%) | Filing History |
| 2024-02-12 4:31 pm Unchanged | 2023-12-31 | 13G | HilleVax, Inc. HLVX | Carlyle Group Inc. CG | 1,838,486 3.800% | 0 (Unchanged) | Filing History |
| 2024-02-12 11:22 am Sale | 2023-12-31 | 13G | The Carlyle Group Inc. CG | MORGAN STANLEY MS | 10,485,962 2.900% | -12,926,684 (-55.21%) | Filing History |
| 2024-02-09 6:14 pm Purchase | 2024-02-07 | 13G | The Carlyle Group Inc. CG | Capital World Investors | 20,008,088 5.500% | 17,791,088 (+802.48%) | Filing History |
| 2024-02-07 4:31 pm Purchase | 2024-01-25 | 13D | Adicet Bio, Inc. ACET | Carlyle Group Inc. CG | 3,060,292 4.100% | 907,333 (+42.14%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | The Carlyle Group Inc. CG | BlackRock Inc. BLK | 31,155,048 8.600% | 31,155,048 (New Position) | Filing History |
| 2024-01-03 4:15 pm Purchase | 2023-12-31 | 13D | CommScope Holding Company, Inc. COMM | Carlyle Group Inc. CG | 42,257,593 16.600% | 2,789,051 (+7.07%) | Filing History |
| 2023-10-16 4:30 pm Purchase | 2023-10-12 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 2,893,615 9.990% | 1,326,368 (+84.63%) | Filing History |
| 2023-10-03 4:05 pm Purchase | 2023-09-28 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 1,567,247 9.990% | 339,930 (+27.70%) | Filing History |
| 2023-09-22 4:22 pm Purchase | 2023-07-28 | 13G | SunPower Corporation SPWR | Carlyle Group Inc. CG | 2,745,879 5.700% | 2,745,879 (New Position) | Filing History |
| 2023-09-14 4:05 pm Purchase | 2023-09-12 | 13D | Carlyle Credit Income Fund CCIF | Carlyle Group Inc. CG | 4,785,628 41.000% | 1,269,537 (+36.11%) | Filing History |
| 2023-08-30 5:19 pm Purchase | 2023-08-28 | 13D | Carlyle Credit Income Fund CCIF | Carlyle Group Inc. CG | 3,516,091 33.800% | 2,672,060 (+316.58%) | Filing History |
| 2023-08-18 4:16 pm Unchanged | 2023-08-08 | 13D | eFFECTOR Therapeutics, Inc. EFTR | Carlyle Group Inc. CG | 193,196 7.800% | 0 (Unchanged) | Filing History |
| 2023-08-18 4:15 pm Purchase | 2023-08-08 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 1,227,317 12.300% | 1,227,317 (New Position) | Filing History |
| 2023-08-02 5:01 pm Sale | 2023-07-18 | 13D | Vera Therapeutics, Inc. VERA | Carlyle Group Inc. CG | 1,872,764 4.200% | -544,073 (-22.51%) | Filing History |
| 2023-07-17 4:40 pm Sale | 2023-07-14 | 13D | Carlyle Credit Income Fund CCIF | Carlyle Group Inc. CG | 844,031 8.100% | -2,874,225 (-77.30%) | Filing History |
| 2023-07-05 4:17 pm Sale | 2023-06-28 | 13D | Vera Therapeutics, Inc. VERA | Carlyle Group Inc. CG | 2,416,837 5.500% | -543,394 (-18.36%) | Filing History |
| 2023-05-10 4:32 pm Unchanged | 2023-05-08 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-05-09 4:31 pm Purchase | 2023-05-02 | 13D | Reneo Pharmaceuticals, Inc. RPHM | Carlyle Group Inc. CG | 273,046 8.200% | 64,250 (+30.77%) | Filing History |
| 2023-04-13 4:06 pm Sale | 2023-03-28 | 13D | Vera Therapeutics, Inc. VERA | Carlyle Group Inc. CG | 2,960,231 6.700% | -9,925 (-0.33%) | Filing History |